免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

Caphosol®人工唾液(32劑包裝盒)

K 號:K234015 · 2024-03-11

決定日期2024-03-11
產品代碼LFD
決定相當於

器材摘要

Caphosol® Artifical Saliva (32 doses sachet box) is the device name listed in this FDA 510(k) record. The listed applicant is Eusa Pharma (Uk) Limited. It received FDA 510(k) clearance on 2024-03-11 under 510(k) number K234015. The device is classified under product code LFD. FDA Decision: Substantially Equivalent.

常見問題

What is the Caphosol® Artifical Saliva (32 doses sachet box)?

Caphosol® Artifical Saliva (32 doses sachet box) is a medical device that received FDA 510(k) clearance on 2024-03-11. The listed applicant is Eusa Pharma (Uk) Limited. The 510(k) number is K234015.

When did Caphosol® Artifical Saliva (32 doses sachet box) receive FDA 510(k) clearance?

Caphosol® Artifical Saliva (32 doses sachet box) received FDA 510(k) clearance on 2024-03-11, under 510(k) number K234015.

Who is the listed applicant for Caphosol® Artifical Saliva (32 doses sachet box)?

The FDA 510(k) record lists Eusa Pharma (Uk) Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Caphosol® Artifical Saliva (32 doses sachet box)?

The FDA product code for Caphosol® Artifical Saliva (32 doses sachet box) is LFD.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Eusa Pharma (Uk) Limited 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:LFD)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑